Recipharm, a global leader in pharmaceutical development and manufacturing, helps bring life-saving drugs from concept to market for companies around the world. As its supplier base expanded, Recipharm faced growing pressure to maintain speed and quality across a complex global network. Limited internal audit capacity, suppliers preferring independent auditors, and short-notice qualification needs from acquisitions and new product launches created mounting bottlenecks.
By partnering with Qualifyze, Recipharm introduced an agile model for supplier qualification, expanding the supplier audit capacity by 50% through a three-year, 50-credit-per-year subscription. The subscription established a scalable, cost-efficient foundation. The partnership now underpins Recipharm’s ability to maintain compliance, ensure supply continuity, and accelerate innovation across its global operations.
As one of the world’s leading contract development and manufacturing organizations (CDMOs), Recipharm manages a vast and evolving supplier landscape—spanning APIs, excipients, bioprocessing systems, medical devices, and clinical materials.
To safeguard product quality and supply continuity, Recipharm’ s global and local Quality teams share responsibility for supplier qualification. Global Quality owns and govern the process, coordinates the annual auditing program and maintains the approved supplier list within the eQMS. Local sites audit suppliers serving individual facilities, while Global Quality manages those supplying multiple locations.
Leave your email to access the full case study and all insights.
